Romain Hany

Romain Hany

Auto-generated profile, based on publicly available information

Romain Hany

UAR 3286 CNRS

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 October 2025 in ChemRxiv
Verified
Preprint
Open access
PDF file
MLMylene LANG
Mylene LANG
SRStéphanie Riché
Stéphanie Riché
LBLucie Brendel
Lucie Brendel
CLClémentine Leger
Clémentine Leger
RHRomain Hany
Romain Hany
LBLine M Bourel-Bonnet
Line M Bourel-Bonnet
Echinocandins (ECs) are semisynthetic lipocyclohexapeptides introduced in the 2000s to treat invasive fungal infections. They selectively and safely inhibit fungal β-(1,3)-D-glucan synthase, a key enzyme for fungal cell wall integrity, but their precise mechanism remains unclear. Their widespread use has led to emerging resistances, underscoring the need for molecular probes to investigate their action and resistance mechanisms. Due to their structural complexity, only few total syntheses and very limited fluorescent analogues have been reported. Here, we present a solid-phase peptide synthesis (SPPS) strategy to readily access to the EC pharmacophore and to novel fluorescent analogues. Using a safety-catch linker resin, cyclization and cleavage are efficiently combined, affording high-purity cyclic lipopeptides with simplifiedpurification step. Depending on the design, fluorescent tags were introduced either on-resin or in solution via bioconjugation. Several analogues retained antifungal activity against Candida albicans, and their interaction with fungal cells was visualized by confocal microscopy. This versatile methodology delivers some of the first fully synthetic fluorescent echinocandins, providing powerful tools to explore their mechanisms of action and fungal resistance.